Rob Williamson - Shockwave Medical VP Sales
Insider
Rob Williamson is VP Sales of Shockwave Medical
| Phone | 510 279 4262 |
| Web | https://shockwavemedical.com |
Shockwave Medical Management Efficiency
The company has return on total asset (ROA) of 0.0868 % which means that it generated a profit of $0.0868 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.2473 %, meaning that it created $0.2473 on every $100 dollars invested by stockholders. Shockwave Medical's management efficiency ratios could be used to measure how well Shockwave Medical manages its routine affairs as well as how well it operates its assets and liabilities.Shockwave Medical currently holds 770.61 M in liabilities with Debt to Equity (D/E) ratio of 0.16, which may suggest the company is not taking enough advantage from borrowing. Shockwave Medical has a current ratio of 5.21, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Shockwave Medical's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Tonya Saffer | Outset Medical | N/A | |
| Waleed MD | TransMedics Group | 57 | |
| Lisa Tatum | Stryker | 53 | |
| JeanOlivier Racine | Outset Medical | 42 | |
| Georgia Melenikiotou | Inspire Medical Systems | 61 | |
| Stacey Porter | Outset Medical | 48 | |
| Jereme Sylvain | DexCom Inc | 44 | |
| Mazin Sabra | Clearpoint Neuro | 44 | |
| Jee HamlynHarris | Penumbra | N/A | |
| Todd Brinton | Edwards Lifesciences Corp | N/A | |
| John Carey | TransMedics Group | 59 | |
| Danilo DAlessandro | Clearpoint Neuro | 40 | |
| Martin Vazquez | Outset Medical | 53 | |
| Paul Flynn | DexCom Inc | 55 | |
| Bryan Phillips | Inspire Medical Systems | 53 | |
| Lambert Shiu | Penumbra | 44 | |
| Preston Wells | Stryker | N/A | |
| Lauren Budden | Insulet | 50 | |
| Spencer Stiles | Stryker | 48 | |
| M Fink | Stryker | 51 | |
| Tamer MD | TransMedics Group | 56 | |
Management Performance
| Return On Equity | 0.25 | |||
| Return On Asset | 0.0868 |
Shockwave Medical Leadership Team
Elected by the shareholders, the Shockwave Medical's board of directors comprises two types of representatives: Shockwave Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Shockwave. The board's role is to monitor Shockwave Medical's management team and ensure that shareholders' interests are well served. Shockwave Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Shockwave Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Isaac Zacharias, Chief Officer | ||
| Debbie Kaster, Vice Relations | ||
| FACC FRCP, Chief Officer | ||
| John Adams, CoFounder Advisor | ||
| Rob Williamson, VP Sales | ||
| Cathy Harnett, Senior Resources | ||
| Hajime JD, General Secretary | ||
| Patrick Stephens, Senior Development | ||
| Renee Gaeta, Chief Officer | ||
| Douglas MBA, CEO President | ||
| Daniel MBA, Principal CFO | ||
| Daniel Hawkins, Founder Advisor | ||
| Mike Maszy, VP Operations | ||
| Trinh Phung, Principal Officer | ||
| Robert Fletcher, Senior Access | ||
| Luis Morales, Senior Operations | ||
| Dave Cox, Vice Sales |
Shockwave Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Shockwave Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.25 | |||
| Return On Asset | 0.0868 | |||
| Profit Margin | 0.21 % | |||
| Operating Margin | 0.19 % | |||
| Current Valuation | 12.32 B | |||
| Shares Outstanding | 37.54 M | |||
| Shares Owned By Insiders | 1.19 % | |||
| Shares Owned By Institutions | 98.72 % | |||
| Number Of Shares Shorted | 1.83 M | |||
| Price To Earning | 178.55 X |
Thematic Opportunities
Explore Investment Opportunities
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Consideration for investing in Shockwave Stock
If you are still planning to invest in Shockwave Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Shockwave Medical's history and understand the potential risks before investing.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |